{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:40:17Z","timestamp":1787060417090,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymgmr.2025.101189","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T09:50:06Z","timestamp":1736934606000},"page":"101189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-term outcomes of enzyme replacement therapy from a large cohort of Korean patients with mucopolysaccharidosis IVA (Morquio A syndrome)"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-6586","authenticated-orcid":false,"given":"Juyoung","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5875-738X","authenticated-orcid":false,"given":"Insung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-844X","authenticated-orcid":false,"given":"Minji","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-7758","authenticated-orcid":false,"given":"Yoon Ji","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Doo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yeon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Rae","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Kun","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eungu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-eun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bae","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kuang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-059X","authenticated-orcid":false,"given":"Sung Yoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.36833","article-title":"Savarirayan R international guidelines for the management and treatment of Morquio a syndrome","volume":"167A","author":"Hendriksz","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.ymgmr.2025.101189_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041517","article-title":"Tomatsu S Mucoolysaccharidosis IVA: Diagnosis, treatment, and management","volume":"21","author":"Sawamoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2025.101189_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"Kleijnen J a systematic review of the prevalence of Morquio a syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2025.101189_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ajmg.a.32781","article-title":"Lin JL incidence of the mucopolysaccharidoses in Taiwan, 1984-2004","volume":"149A","author":"Lin","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.ymgmr.2025.101189_bb0025","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/humu.24270","article-title":"Tomanin R molecular basis of mucopolysaccharidosis IVA (Morquio a syndrome): a review and classification of GALNS gene variants and reporting of 68 novel variants","volume":"42","author":"Zanetti","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2025.101189_bb0030","first-page":"59","article-title":"Hendriksz C mortality in patients with morquio syndrome A","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep."},{"issue":"6","key":"10.1016\/j.ymgmr.2025.101189_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","article-title":"Lo JH Elosulfase alfa: first global approval","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.ymgmr.2025.101189_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12081338","article-title":"Lin SP efficacy of intravenous Elosulfase alfa for Mucopolysaccharidosis type IVA: a systematic review and Meta-analysis","volume":"12","author":"Lee","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymgmr.2025.101189_bb0045","article-title":"Ko JM clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA","volume":"31","author":"Lee","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101189_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ajmg.a.35298","article-title":"Jin DK five novel mutations of GALNS in Korean patients with mucopolysaccharidosis IVA","volume":"161A","author":"Park","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.ymgmr.2025.101189_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3345\/kjp.2012.55.11.430","article-title":"Jin DK clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA","volume":"55","author":"Lee","year":"2012","journal-title":"Korean J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgmr.2025.101189_bb0060","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Dummer W efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio a syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2025.101189_bb0065","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinthera.2014.11.005","article-title":"O\u2019Neill CA immunogenicity of Elosulfase alfa, an enzyme replacement therapy in patients with Morquio a syndrome: results from MOR-004, a phase III trial","volume":"37","author":"Schweighardt","year":"2015","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-017-0633-1","article-title":"Bhattacharya K minimal clinically important difference for the 6-min walk test: literature review and application to Morquio a syndrome","volume":"12","author":"Schrover","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101189_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1620\/tjem.203.189","article-title":"Kohzuki M development of the Korean version of short-form 36-item health survey: health related QOL of healthy elderly people and elderly patients in Korea","volume":"203","author":"Han","year":"2004","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2025.101189_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pmn.2019.06.004","article-title":"Badr LK translation, cross-cultural adaptation, and validation of the adolescent pediatric pain tool (APPT) for multidimensional measurement of pain in children and adolescents","volume":"20","author":"Madi","year":"2019","journal-title":"Pain Manag. Nurs."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101189_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/000841749005700207","article-title":"Pollock N the Canadian occupational performance measure: an outcome measure for occupational therapy","volume":"57","author":"Law","year":"1990","journal-title":"Can. J. Occup. Ther."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101189_bb0090","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ymgme.2018.12.289","article-title":"Hamed a qualitative interviews with patients with mucopolysaccharidosis type I (MPS I) and caregivers to evaluate the Mucopolysaccharidosis health assessment questionnaire (MPS-HAQ)","volume":"126","author":"Pabla","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0095","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.1038\/s41598-019-46829-x","article-title":"Chuang CK normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis","volume":"9","author":"Lin","year":"2019","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.ymgmr.2025.101189_bb0100","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4155\/bio.11.172","article-title":"Foehr ED validation of an LC-MS\/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio a syndrome","volume":"3","author":"Martell","year":"2011","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/abio.2000.4940","article-title":"Imanari T analytical method for keratan sulfates by high-performance liquid chromatography\/turbo-ionspray tandem mass spectrometry","volume":"290","author":"Oguma","year":"2001","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101189_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00256-013-1797-y","article-title":"White KK Mucopolysaccharidosis IVA (Morquio a syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose","volume":"43","author":"Lachman","year":"2014","journal-title":"Skeletal Radiol."},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101189_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jimd.12491","article-title":"Zhang H investigation of GALNS variants and genotype-phenotype correlations in a large cohort of patients with mucopolysaccharidosis type IVA","volume":"45","author":"Yi","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13023-019-1105-6","article-title":"Ngu LH clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio a syndrome) in Malaysia: the first national natural history cohort study","volume":"14","author":"Leong","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101189_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-9-21","article-title":"Lin SP natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA","volume":"9","author":"Lin","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2025.101189_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","article-title":"Tomatsu S Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101189_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13023-019-1074-9","article-title":"Committee MPSCPS, co-chairs MPSCP recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance","volume":"14","author":"Akyol","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2025.101189_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/ahg.12483","article-title":"Cho SY a novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences","volume":"86","author":"Kim","year":"2022","journal-title":"Ann. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101189_bb0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2017.11.015","article-title":"Harmatz PR impact of long-term elosulfase alfa on activities of daily living in patients with Morquio a syndrome in an open-label, multi-center, phase 3 extension study","volume":"123","author":"Hendriksz","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2025.101189_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2022.08.007","article-title":"Stepien KM findings from the Morquio a registry study (MARS) after 6 years: long-term outcomes of MPS IVA patients treated with elosulfase alfa","volume":"137","author":"Mitchell","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101189_bb0160","article-title":"The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: a longitudinal analysis","volume":"20","author":"Kenth","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"11","key":"10.1016\/j.ymgmr.2025.101189_bb0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","article-title":"Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio a syndrome): effect and limitations","volume":"3","author":"Tomatsu","year":"2015","journal-title":"Expert Opin. Orphan Drugs"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:19:58Z","timestamp":1740694798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"alternative-id":["S2214426925000047"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101189","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of enzyme replacement therapy from a large cohort of Korean patients with mucopolysaccharidosis IVA (Morquio A syndrome)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101189"}}